Authors : M. Mohammed kaif ; M. Dheenadhayalan

Volume/Issue : Volume 10 - 2025, Issue 5 - May

Google Scholar : https://tinyurl.com/2c839n3y

DOI : https://doi.org/10.38124/ijisrt/25may1619

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Postoperative pain management is a critical aspect of patient care, with various analgesic options available to optimize recovery while minimizing adverse effects. This review compares pentazocine and tramadol, two commonly used analgesics, in terms of their pharmacological profiles, mechanisms of action, efficacy, safety, and side effects. Tramadol, a serotonin norepinephrine reuptake inhibitor (SNRI) and a centrally acting opioid has shown effective pain relief with a lower risk of respiratory depression and dependency. Pentazocine, a mixed opioid agonist-antagonist, provides analgesia with a ceiling effect, reducing the risk of overdose but potentially causing dysphoria and hallucinogenic effects at higher doses. Studies indicate that tramadol may offer superior pain relief in the immediate postoperative period compared to pentazocine, particularly due to its dual mechanism of action and fewer cardiorespiratory side effects. However, pentazocine may provide better hemodynamic stability and remains a viable option in certain patient populations. Both drugs have distinct adverse effect profiles, with tramadol linked to serotonin syndrome and seizures, and pentazocine associated with drowsiness, respiratory depression, and dependency risks. The choice between tramadol and pentazocine should be based on individual patient factors, pain severity, and risk-benefit considerations. While tramadol is generally preferred due to its tolerability and balanced analgesic effect, pentazocine remains relevant in select cases. Further research and personalized pain management approaches are necessary to improve patient outcomes.

Keywords : Postoperative Pain, Tramadol, Pentazocine Analgesics Efficacy, Safety, Side Effects, Opioid, Pain Relief, Dependency.

References :

1. A Comparative Study of Analgesic Effects of Tramadol and Pentazocine for Major Abdominal Procedures. ARC J Anesthesiol [Internet]. .2016[cited 2025 Feb 6];1(3). Available. From https://www.arcjournals.org/pdfs/aja/v1-i3/4.pdf  Fromhttps://www.arcjournals.org/pdfs/aja/v1-i3/4.pdf
2. Kuti O, Faponle A, Adeyemi A, Owolabi A. Pain Relief in labour: A randomized controlled trial comparing pentazocine with Tramadol. Nepal J Obstet Gynaecol. 1970 Jan 1;3(1):14–8. 
3. Cibulsky SM, Wille T, Funk R, Sokolowski D, Gagnon C, Lafontaine M, Brevett C, Jabbour R, Cox J, Russell DR, Jett DA. Public health and medical preparedness for mass casualties from the deliberate release of synthetic opioids. Frontiers in public health. 2023 May 12;11:1158479.
4. Pentazocine Versus Pentazocine With Rectal Diclofenac For Postoperative Pain Relief After Cesarean Section.pdf [Internet]. [cited 2025 Feb 3]. Available from: https://www.aub.edu.lb/fm/Ane sthesiology/meja/Documents/Pentazocine%20Versus%20Pentazocine%20With%20Rectal%20Diclofenac%20For%20Postoperative%20Pain%20Relief%20After%20Cesarean%20Section.pdf
5. Kuti O, Faponle AF. Perception of labour pain among the Yoruba ethnic group in Nigeria. J Obstet Gynaecol. 2006 Jan;26(4):332–4. 
6. Dnyanoba JY, P GU. Randomized comparison of efficacy, duration of action, adverse reactions and cost effectiveness of pentazocine and tramadol on relief of post operative pain. Int J Curr Res Physiol Pharmacol. 2018 Oct 20;1–4. 
7. McDonnell JG, O??Donnell B, Curley G, Heffernan A, Power C, Laffey JG. The Analgesic Efficacy of Transversus Abdominis Plane Block After Abdominal Surgery: A Prospective Randomized Controlled Trial: Anesth Analg. 2007 Jan;104(1):193–7. 
8. Finn P. Empathizing with addicts. Health Educ. 1978;9(2):40–1. 
9. Schein PS, Winokur SH. Immunosuppressive and cytotoxic chemotherapy: long-term complications. Ann Intern Med. 1975 Jan;82(1):84–95. 
10. Pentazocine. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases;              2012 [cited            2025       Mar        21]. Available from:http://w ww.ncbi.nlm.nih.gov/books/NBK548498/
11. Kuper’s R, Callebaut V, Debois V, Camu F, Verburg C, Coppejans H, et al. Efficacy and safety of oral tramadol and pentazocine for postoperative pain following prolapsed intervertebral disc repair. Acta Anaesthesiol Belg. 1995;46(1):31–7. 
12. Bano B, Bai K, Jumani S, Bashir N, Mohsin H, Laghari S, et al. Effectiveness of tramadol compared to pentazocine in pain management during labour. Int J Community Med Public Health. 2021 Aug 27;8(9):4216. 
13. Levine JD, Gordon NC. Synergism between the analgesic actions of morphine and pentazocine. Pain. 1988 Jun;33(3):369–72. 
14. Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice. Res Commun Chem Pathol Pharmacol. 1994 Apr;84(1):105–10. 
15. Pentazocine. In: Liver Tox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases, 2012 [cited         2025       Mar        21]. Available from:http://www.ncbi.nlm .nih.gov/books/NBK548498/
16. Shannon MW, Borron SW, Burns MJ, Haddad LM, Winchester JF, editors. Haddad and Winchester’s clinical management of poisoning and drug overdose. 4th ed. Philadelphia: Saunders/Elsevier; 2007. 1559 p. 
17. Persson P, Brynhildsen J, Kjølhede P, Hysterectomy Multicentre Study Group in SouthEast Sweden. A 1-year follow up of psychological wellbeing after subtotal and total hysterectomy--a randomised study. BJOG Int J Obstet Gynaecol. 2010 Mar;117(4):479–87. 
18. Suzuki T, Masukawa Y, Shiozaki Y, Misawa M. Potentiation of pentazocine conditioned place preference by tripelennamine in rats. Psychopharmacology (Berl). 1991;105(1):9–12. 
19. Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, et al. Maintenance of the long-term effectiveness of tramadol in the treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000 Mar;14(2):65–70. 
20. Gong L, Stamer UM, Tzvetkov MV, Altman RB, Klein TE. PharmGKB summary: tramadol pathway. Pharmacogenet Genomics. 2014 Jul;24(7):374–80. 
21. Martyn-St James M, Cooper K, Kaltenthaler E, Dickinson K, Cantrell A, Wylie K, et al. Tramadol for premature ejaculation: a systematic review and meta-analysis. BMC Urol. 2015 Dec;15(1):6. 
22. Gong L, Stamer UM, Tzvetkov MV, Altman RB, Klein TE. PharmGKB summary: tramadol pathway. Pharmacogenet Genomics. 2014 Jul;24(7):374–80. 
23. Adeniji A, Atanda. Randomized comparison of effectiveness of unimodal opioid analgesia with multimodal analgesia in post– cesarean section pain management. J Pain Res. 2013 May;419. 
24. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923. 
25. Turturro MA, Paris PM, Larkin GL. Tramadol Versus Hydrocodone-Acetaminophen in Acute Musculoskeletal Pain: A Randomized, Double-Blind Clinical Trial. Ann Emerg Med. 1998 Aug;32(2):139–43. 
26. Magrini M, Rivolta G, Bolis C, Furiosi D. Analgesic activity of tramadol and pentazocine in postoperative pain. Int J Clin Pharmacol Res. 1998;18(2):87–92. 
27. Bano B, Bai K, Jumani S, Bashir N, Mohsin H, Laghari S, et al. Effectiveness of tramadol compared to pentazocine in pain management during labour. Int J Community Med Public Health. 2021 Aug 27;8(9):4216. 
28. Kupers R, Callebaut V, Debois V, Camu F, Verborgh C, Coppejans H, et al. Efficacy and safety of oral tramadol and pentazocine for postoperative pain following prolapsed intervertebral disc repair. Acta Anaesthesiol Belg. 1995;46(1):31–7. 
29. Shetty J, Vishalakshi A, Pandey D. Labour Analgesia When Epidural Is Not a Choice: Tramadol versus Pentazocine. ISRN Obstet Gynecol. 2014 Apr 7;2014:1–4. 
30. Wang N, Wang L, Gao Y, Zhou H, Wang J. Analgesic Effect of Preoperative Pentazocine for Laparoscopic Cholecystectomy. Cureus. 2016 Dec 31;8(12):e948. 
31. Sowards A, O’Neil MG, Kullgren JG, Silva JM. Opioid analgesics and narcotic antagonists. In: Side Effects of Drugs Annual [Internet]. Elsevier; 2020 [cited 2025 Mar 21]. p. 115–26. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0378608020300271
32. Kuroiwa R, Handa S, Inomata K, Kato Y. The Effect of Pentazocine on Nausea and Vomiting Following Catheter Ablation. Showa Univ J Med Sci. 2020;32(1):103–11. 
33. Baum C, Hsu JP, Nelson RC. The impact of the addition of naloxone on the use and abuse of pentazocine. Public Health Rep Wash DC 1974. 1987;102(4):426–9. 
34. Oshikoya KA, Abayomi Ogunyinka I, Godman B. Off-label use of pentazocine and the associated adverse events among pediatric surgical patients in a tertiary hospital in Northern Nigeria: a retrospective chart review. Curr Med Res Opin. 2019 Sep 2;35(9):1505–12. 
35. Oshikoya KA, Abayomi Ogunyinka I, Godman B. Off-label use of pentazocine and the associated adverse events among pediatric surgical patients in a tertiary hospital in Northern Nigeria: a retrospective chart review. Curr Med Res Opin. 2019 Sep 2;35(9):1505–12. 
36. Hassamal S, Miotto K, Dale W, Danovitch I. Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures. Am J Med. 2018 Nov;131(11):1382.e1-1382.e6. 
37. Shiraishi M, Minami K, Uezono Y, Yanagihara N, Shigematsu A, Shibuya I. Inhibitory effects of tramadol on nicotinic acetylcholine receptors in adrenal chromaffin cells and in Xenopus oocytes expressing α7 receptors. Br J Pharmacol. 2002 May;136(2):207–16. 
38. Sawynok J, Reid AR, Liu J. Spinal and peripheral adenosine A₁ receptors contribute to antinociception by tramadol in the formalin test in mice. Eur J Pharmacol. 2013 Aug 15;714(1– 3):373–8. 
39. Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, et al. Maintenance of the long-term effectiveness of tramadol in the treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000;14(2):65–70. 
40. Asai T, Mapleson WW, Power I. Effects of nalbuphine, pentazocine and U50488H on gastric emptying and gastrointestinal transit in the rat. Br J Anaesth. 1998 Jun;80(6):814–9. 
41. Opadiran RO, Isah DA, Offiong R, Asudo FD.Pentazocine versus tramadol-paracetamol combination as analgesia in labor: A randomized controlled trial. Ann Med Res Pract. 2022 Jun 2;3:4. 
42. Shetty J, Vishalakshi A, Pandey D. Labour Analgesia When Epidural Is Not a Choice: Tramadol versus Pentazocine. ISRN Obstet Gynecol. 2014 Apr 7;2014:1–4. 
43. Kuti O, Faponle A, Adeyemi A, Owolabi A. Pain Relief in labour: A randomized controlled trial comparing pentazocine with Tramadol. Nepal J Obstet Gynaecol. 1970 Jan 1;3(1):14–8. 
44. Befeler D, Giattini JF. PENTAZOCINE INTRAMUSCULARLY FOR CONTROL OF POSTOPERATIVE PAIN IN ORTHOPEDIC PATIENTS. J Am Geriatr Soc. 1970 Dec;18(12):962–7. 
45. Magrini M, Rivolta G, Bolis C, Furiosi D. Analgesic activity of tramadol and pentazocine in postoperative pain. Int J Clin Pharmacol Res. 1998;18(2):87–92. 
46. Shetty J, Vishalakshi A, Pandey D. Labour Analgesia When Epidural Is Not a Choice:Tramadol versus Pentazocine. ISRN Obstet Gynecol. 2014 Apr 7;2014:1–4.
47. Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000 Mar;14(2):65–70. 
48. Göbel H, Stadler Th. Traitement des douleurs post-zostériennes par le tramadol: Résultats dʼune étude pilote ouverte versus clomipramine avec ou sans lévomépromazine†.Drugs.1997;53(Supplement 2):34–9. 
49. Magrini M, Rivolta G, Bolis C, Furiosi D. Analgesic activity of tramadol and pentazocine in postoperative pain. Int J Clin Pharmacol Res. 1998;18(2):87–92. 
50. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923. 
51. Dnyanoba JY, Up G. RANDOMIZED COMPARISON OF EFFICACY, DURATION OF ACTION, ADVERSE REACTIONS AND COST EFFECTIVENESS OF PENTAZOCINE AND TRAMADOL ON RELIEF OF POST OPERATIVE PAIN. 
52. Cao L, Yang T, Hou Y, Yong S, Zhou N. Efficacy and Safety of Different Preemptive Analgesia Measures in Pain Management after Laparoscopic Cholecystectomy: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Pain Ther. 2024 Dec;13(6):1471–97. 
53. Koyyalagunta D. Opioid Analgesics. In: Pain Management [Internet]. Elsevier; 2007 [cited 2025        Mar 22]. p. 939–64. Availablefrom:https://linkinghub.elsevier.com/retrieve/pii/B9780721603346501175
54. Khan ZU, Razzaq A, Khan A, Rehman NU, Khan H, Khan T, et al. Physicochemical Characterizations and Pharmacokinetic Evaluation of Pentazocine Solid Lipid Nanoparticles against Inflammatory Pain Model. Pharmaceutics. 2022 Feb 14;14(2):409. 
55. Dayer P, Desmeules J, Collart L. [Pharmacology of tramadol]. Drugs. 1997;53 Suppl 2:18–24. 
56. Vazzana M, Andreani T, Fangueiro J, Faggio C, Santini A, Garcia ML, et al. Tramadol hydrochloride: Pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs, and new drug delivery systems. Biomed Pharmacother. 2015 Mar;70:234–8. 
57. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923. 
58. Chien CC, Pasternak GW. (-)-Pentazocine analgesia in mice: interactions with a sigma receptor system. Eur J Pharmacol. 1995 Dec 27;294(1):303–8. 
59. Dun Y, Thangaraju M, Prasad P, Ganapathy V, Smith SB. Prevention of excitotoxicity in primary retinal ganglion cells by (+)-pentazocine, a sigma receptor-1 specific ligand. Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4785–94. 
60. Khan ZU, Razzaq A, Khan A, Rehman NU, Khan H, Khan T, et al. Physicochemical Characterizations and Pharmacokinetic Evaluation of Pentazocine Solid Lipid Nanoparticles against Inflammatory Pain Model. Pharmaceutics. 2022 Feb 14;14(2):409. 
61. Berkowitz B, Way EL. Metabolism and excretion of pentazocine in man. Clin Pharmacol Ther. 1969 Sep;10(5):681–9. 
62. Kantor TG, Sunshine A, Laska E, Meisner M, Hopper M. Oral analgesic studies: Pentazocine hydrochloride, codeine, aspirin, and placebo and their influence on response to placebo. Clin Pharmacol Ther. 1966 Jul;7(4):447–54. 
63. Khan ZU, Razzaq A, Khan A, Rehman NU, Khan H, Khan T, et al. Physicochemical Characterizations and Pharmacokinetic Evaluation of Pentazocine Solid Lipid Nanoparticles against Inflammatory Pain Model. Pharmaceutics. 2022 Feb 14;14(2):409. 
64. Moriki Y, Suzuki T, Fukami T, Hanano M, Tomono K, Watanabe J. Involvement of Pglycoprotein in Blood-Brain Barrier Transport of Pentazocine in Rats Using Brain Uptake Index Method. Biol Pharm Bull. 2004;27(6):932–5. 
65. Pentazocine. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases;              2012 [cited            2025       Mar        22]. Available from:http://www.ncbi.nlm.nih.gov/books/NBK548498/
66. Monteiro BP, Klinck MP, Moreau M, Guillot M, Steagall PVM, Pelletier JP, et al. Analgesic efficacy of tramadol in cats with naturally occurring osteoarthritis. PloS One. 2017;12(4):e0175565. 
67. Vadivelu N, Chang D, Helander EM, Bordelon GJ, Kai A, Kaye AD, et al. Ketorolac, Oxymorphone, Tapentadol, and Tramadol. Anesthesiol Clin. 2017 Jun;35(2):e1–20. 
68. Grond S, Sablotzki A. Clinical Pharmacology of Tramadol: Clin Pharmacokinet. 2004;43(13):879–923. 

69. Lauder G, Emmott A. Confronting the challenges of effective pain management in children following tonsillectomy. Int J Pediatr Otorhinolaryngol. 2014 Nov;78(11):1813–27. 
70. Stern SS, Ponticello MN. Current Concepts in Pain Management: Pharmacologic Options for the Pediatric, Geriatric, Hepatic and Renal Failure Patient. Clin Podiatr Med Surg. 2008 Jul;25(3):381–407. 
71. Vadivelu N, Chang D, Helander EM, Bordelon GJ, Kai A, Kaye AD, et al. Ketorolac, Oxymorphone, Tapentadol, and Tramadol. Anesthesiol Clin. 2017 Jun;35(2):e1–20. 
72. Dayer P, Desmeules J, Collart L. [Pharmacology of tramadol]. Drugs. 1997;53 Suppl 2:18–24. 
73. Beakley BD, Kaye AM, Kaye AD. Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review. Pain Physician. 2015;18(4):395–400. 
74. Laskarides C. Update on Analgesic Medication for Adult and Pediatric Dental Patients. Dent Clin North Am. 2016 Apr;60(2):347–66. 
75. Yip L, Mégarbane B, Borron SW. Opioids. In: Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose [Internet]. Elsevier; 2007 [cited 2025 Mar 24]. p. 635–58.Available from https://linkinghub.elsevier.com/retrieve/pii/B9780721606934500384
76. Pawar A, Rajalakshmi AK, Upadhyay RP. Pentazocine use among people who inject drugs in India. Asian J Psychiatry. 2015 Aug;16:3–6. 
77. Chien CC, Pasternak GW. (-)-Pentazocine analgesia in mice: interactions with a sigma receptor system. Eur J Pharmacol. 1995 Dec 27;294(1):303–8. 
78. Berkowitz BA, Asling JH, Shnider SM, Way EL. Relationship of pentazocine plasma levels to pharmacological activity in man. Clin Pharmacol Ther. 1969 May;10(3):320–8. 
79. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923. 
80. Barakat A. Revisiting Tramadol: A Multi-Modal Agent for Pain Management. CNS Drugs. 2019 May 1;33(5):481–501. 
81. Epstein DH, Preston KL, Jasinski DR. Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol. 2006 Jul;73(1):90–9. 
82. Agurell S, Boréus LO, Gordon E, Lindgren JE, Ehrnebo M, Lönroth U. Plasma and cerebrospinal fluid concentrations of pentazocine in patients: assay by mass fragmentography. J Pharm Pharmacol. 1974 Jan 1;26(1):1–8. 
83. Goldstein G. Pentazocine. Drug Alcohol Depend. 1985 Feb;14(3–4):313–23. 
84. Berkowitz BA, Asling JH, Shnider SM, Way EL. Relationship of pentazocine plasma levels to pharmacological activity in man. Clin Pharmacol Ther. 1969 May;10(3):320–8. 
85. Vaughan DP, Beckett AH. An analysis of the inter-subject variation in the metabolism of pentazocine. J Pharm Pharmacol. 1974 Oct 1;26(10):789–98. 
86. Sandoval RG, Wang RIH. Tolerance and Dependence on Pentazocine. N Engl J Med. 1969 Jun 19;280(25):1391–2. 
87. Ward-McQuaid JN, Chakrabarti S. Pentazocine Suppositories for Post-Operative Pain: Intramuscular Pentazocine Injections versus Suppositories in a Controlled Trial in 588 Patients. J Int Med Res. 1977 Jul;5(4):281–8. 
88. Goldstein G. Pentazocine. Drug Alcohol Depend. 1985 Feb;14(3–4):313–23. 
89. Wood AJJ, Moir DC, Campbell C, Davidson JF, Gallon SC, Henney E, et al. Medicines Evaluation and Monitoring Group: Central Nervous System Effects of Pentazocine. BMJ. 1974 Feb 23;1(5903):305–7. 
90. Prakash J, Saini R. Tramadol Dependence: A Case Report. Med J Armed Forces India. 2010 Jan;66(1):93–4. 
91. Tjäderborn M, Jönsson AK, Ahlner J, Hägg S. Tramadol dependence: a survey of spontaneously reported cases in Sweden. Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1192–8. 
92. Abdel-Zaher AO, Abdel-Rahman MS, ELwasei FM. Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: Role of nitric oxide and oxidative stress. NeuroToxicology. 2011 Dec;32(6):725–33. 
93. Frey H. Interactions between Morphine‐like Analgesics and Anticonvulsant Drugs. Pharmacol Toxicol. 1987 Mar;60(3):210–3. 
94. Carmignani M, Scoppetta C, Ranelletti FO, Tonali P. Adverse interaction between acetazolamide and anticholinesterase drugs at the normal and myasthenic neuromuscular junction level. Int J Clin Pharmacol. 1984 Mar;22(3):140–4. 
95. Hollister LE. Acetophenazine and Diazepam in Anxious Depressions. Arch Gen Psychiatry. 1971 Mar 1;24(3):273. 
96. Jones P. Aclidinium Bromide Twice Daily for the Treatment of Chronic Obstructive Pulmonary Disease: A Review. Adv Ther. 2013 Apr;30(4):354–68. 
97. Millan MJ, Brocco M, Gobert A, Dekeyne A. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl). 2005 Feb;177(4):448–58. 
98. Clarot F, Goullé JP, Vaz E, Proust B. Fatal overdoses of tramadol: is benzodiazepine a risk factor of lethality? Forensic Sci Int. 2003 Jun;134(1):57–61. 
99. Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, et al. TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024 Jan 5;52(D1):D1465–77. 
100. Bowles VM, Yoon KS, Barker SC, Tran C, Rhodes C, Clark MJ. Ovicidal Efficacy of Abametapir Against Eggs of Human Head and Body Lice (Anoplura: Pediculidae). J Med Entomol. 2017 Jan;54(1):167–72. 
101. Moreland L, Bate G, Kirkpatrick P. Abatacept. Nat Rev Drug Discov. 2006 Mar;5(3):185–6. 

102. James A, Vincent B, Sivadas A, Pavithran K. A Study on the Clinical Outcome of Abiraterone Acetate in Castration Resistant Prostate Cancer Patients. Int J Hematol-Oncol Stem Cell Res. 2018 Jan 1;12(1):4–7. 
103. Juba KM, Van Manen RP, Fellows SE. A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related Hypoglycemia. Ann Pharmacother. 2020 Mar;54(3):247–53. 
104. Kotagale NR, Upadhya M, Hadole PN, Kokare DM, Taksande BG. Involvement of hypothalamic neuropeptide Y in pentazocine induced suppression of food intake in rats. Neuropeptides. 2014 Jun;48(3):133–41. 
105. Hamunen K, Olkkola KT, Seppäiä T, Maunuksela E. Pharmacokinetics and Pharmacodynamics of Pentazocine in Children. Pharmacol Toxicol. 1993 Aug;73(2):120–3. 
106. Holmes B, Ward A. Meptazinol: A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy. Drugs. 1985 Oct;30(4):285–312. 
107. Stoops WW, Lofwall MR, Nuzzo PA, Craig LB, Siegel AJ, Walsh SL. Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment. Psychopharmacology (Berl). 2012 Oct;223(4):427–38. 
108. Vazzana M, Andreani T, Fangueiro J, Faggio C, Silva C, Santini A, et al. Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems. Biomed Pharmacother Biomedecine Pharmacother. 2015 Mar;70:234–8. 
109. Hara K, Minami K, Sata T. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Anesth Analg. 2005 May;100(5):1400–5. 
110. Hassamal S, Miotto K, Dale W, Danovitch I. Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures. Am J Med. 2018 Nov;131(11):1382.e1-1382.e6. 
111. Shiraishi M, Minami K, Uezono Y, Yanagihara N, Shigematsu A, Shibuya I. Inhibitory effects of tramadol on nicotinic acetylcholine receptors in adrenal chromaffin cells and in Xenopus oocytes expressing alpha 7 receptors. Br J Pharmacol. 2002 May;136(2):207–16.